CN Patent

CN114761002A — 用于奥美拉唑混悬剂的组合物和试剂盒

Assigned to Azuriti Pharmaceutical Co · Expires 2022-07-15 · 4y expired

What this patent protects

本文公开了用于制备质子泵抑制剂(例如奥美拉唑)的复溶的混悬剂的液体稀释剂、制剂和试剂盒。本公开还提供了用于液体稀释剂的制剂，所述制剂在暴露于冻融循环后不具有形成凝胶的趋势。

USPTO Abstract

本文公开了用于制备质子泵抑制剂(例如奥美拉唑)的复溶的混悬剂的液体稀释剂、制剂和试剂盒。本公开还提供了用于液体稀释剂的制剂，所述制剂在暴露于冻融循环后不具有形成凝胶的趋势。

Drugs covered by this patent

Prilosec (omeprazole) · AstraZeneca (originally Astra AB)

Patent Metadata

Patent number: CN114761002A
Jurisdiction: CN
Classification: —
Expires: 2022-07-15
Drug substance claim: No
Drug product claim: No
Assignee: Azuriti Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.